Nvidia-Backed Iambic Therapeutics Files for Nasdaq IPO
Iambic Therapeutics, which raised $461.8 million from Nvidia and others, filed Monday for a Nasdaq IPO under ticker IAM to fund three cancer-drug programs.
Topic
Iambic Therapeutics
Topic
Iambic Therapeutics
Iambic Therapeutics Files for IPO as AI Drug Discovery Heats Up
AI drug discovery startup Iambic Therapeutics has filed for an initial public offering, Yahoo Finance reports, testing investor a…
Iambic Therapeutics Files for IPO
AI drug discovery startup Iambic Therapeutics has filed for an initial public offering, MarketScreener reports, joining the wave…